Details of the Drug Reposition

General Information of This Drug (ID: DMOI9EL)

Drug Name
Radezolid   DMOI9EL
Synonyms
Radezolid; Radezolid hydrochloride; RX-103; RX-1741; RX-01-667; Oxazolidinone antibiotic (bacterial infection), Rib-X Pharmaceuticals; Oxazolidinone antibiotic (CAP/uSSSI), Rib-X Pharamceuticals; Radezolid (iv, gram positive bacterial infection), Rib-X Pharmaceuticals; RX-1741 (iv, gram positive bacterial infection), Rib-X Pharmaceuticals; Radezolid (oral, CAP/uSSSI), Rib-X Pharmaceuticals; RX-1741 (oral, CAP/uSSSI), Rib-X Pharmaceuticals
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pneumonia DIS8EF3M CA40 Phase 2 [1]
Acne vulgaris DISKW8PI ED80 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00640926) Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)